PubRank

Itai Bab

Author PubWeight™ 37.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A 2006 1.95
2 Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrual. Proc Natl Acad Sci U S A 2012 1.56
3 Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes. Proc Natl Acad Sci U S A 2013 1.54
4 Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proc Natl Acad Sci U S A 2008 1.46
5 Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A 2009 1.44
6 Prediction of fracture callus mechanical properties using micro-CT images and voxel-based finite element analysis. Bone 2005 1.33
7 Depression induces bone loss through stimulation of the sympathetic nervous system. Proc Natl Acad Sci U S A 2006 1.22
8 Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet 2005 1.13
9 Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis. Bone 2006 1.13
10 Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. J Cell Physiol 2006 1.11
11 Major depression is a risk factor for low bone mineral density: a meta-analysis. Biol Psychiatry 2009 1.10
12 Lef1 haploinsufficient mice display a low turnover and low bone mass phenotype in a gender- and age-specific manner. PLoS One 2009 1.08
13 Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton. J Biol Chem 2012 1.05
14 Central IL-1 receptor signaling regulates bone growth and mass. Proc Natl Acad Sci U S A 2005 1.04
15 The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J 2007 1.04
16 Endosseous implant anchorage is critically dependent on mechanostructural determinants of peri-implant bone trabeculae. J Bone Miner Res 2010 1.02
17 Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol Pharmacol 2006 1.01
18 Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass. Proc Natl Acad Sci U S A 2010 0.99
19 Transplanted blood-derived endothelial progenitor cells (EPC) enhance bridging of sheep tibia critical size defects. Bone 2009 0.98
20 CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts. J Bone Miner Res 2011 0.94
21 N-Acyl amino acids and their impact on biological processes. Biofactors 2014 0.93
22 Osteogenic growth peptide modulates fracture callus structural and mechanical properties. Bone 2004 0.93
23 Microarchitectural changes in the aging skeleton. Curr Osteoporos Rep 2011 0.91
24 Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivo. Nucleic Acids Res 2005 0.90
25 Differential load-regulated global gene expression in mouse trabecular osteocytes. Bone 2012 0.87
26 Dextran sodium sulfate-induced colitis causes rapid bone loss in mice. Bone 2008 0.86
27 ERK1/2-activated de novo Mapkapk2 synthesis is essential for osteogenic growth peptide mitogenic signaling in osteoblastic cells. J Biol Chem 2005 0.86
28 Does simvastatin stimulate bone formation in vivo? BMC Musculoskelet Disord 2003 0.86
29 Intermittently administered parathyroid hormone 1-34 reverses bone loss and structural impairment in orchiectomized adult rats. Osteoporos Int 2005 0.86
30 Mechanical loading of mouse caudal vertebrae increases trabecular and cortical bone mass-dependence on dose and genotype. Biomech Model Mechanobiol 2010 0.85
31 Osteocalcin-insulin relationship in obese children: a role for the skeleton in energy metabolism. Clin Endocrinol (Oxf) 2011 0.84
32 Bioactive pseudopeptidic analogues and cyclostereoisomers of osteogenic growth peptide C-terminal pentapeptide, OGP(10-14). J Med Chem 2002 0.83
33 Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats. Gastroenterology 2007 0.82
34 New approach to quantifying developmental variation in the dentition using serial microtomographic imaging. Microsc Res Tech 2004 0.78
35 Restrain of bone growth by estrogen-mimetic peptide-1 (EMP-1): a micro-computed tomographic study. Peptides 2009 0.77
36 Trabecular bone gradient in rat long bone metaphyses: mathematical modeling and application to morphometric measurements and correction of implant positioning. J Bone Miner Res 2008 0.76
37 Themed issue on cannabinoids in biology and medicine. Br J Pharmacol 2011 0.76
38 CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol. Ann N Y Acad Sci 2015 0.75
39 Behavioural changes induced by a conditional disruption of bone formation. J Basic Clin Physiol Pharmacol 2016 0.75